Get Premium to unlock powerful stock data
FRA:HO1 (USA)  
Hologic Inc logo

Hologic Inc

€ 65.30 (-0.96%) Jul 1
On watch
P/E:
11.56
P/B:
3.65
Market Cap:
€ 16.70B ($ 17.41B)
Enterprise V:
€ 17.46B ($ 18.21B)
Volume:
-
Avg Vol (2M):
100.00
Also Trade In:
Volume:
-
Market Cap €:
16.70B
Market Cap $:
17.41B
PE Ratio:
11.56
Avg Vol (2-Month):
100.00
Enterprise Value €:
17.46B
Enterprise Value $:
18.21B
PB Ratio:
3.65
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Name Current Vs Industry Vs History
Cash-To-Debt 0.74
Equity-to-Asset 0.5
Debt-to-Equity 0.65
Debt-to-EBITDA 1.25
Interest Coverage 22.02
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.01
Distress
Grey
Safe
Beneish M-Score -3.4
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 41.07
9-Day RSI 41.58
14-Day RSI 41.98
6-1 Month Momentum % 7.97
12-1 Month Momentum % 23.94

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.97
Quick Ratio 2.57
Cash Ratio 1.76
Days Inventory 94.78
Days Sales Outstanding 66.16
Days Payable 40.73

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 2.1

Financials (Next Earnings Date:2022-07-28 Est.)

FRA:HO1's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 4,694.338
EPS (TTM) (€) 5.311
Beta 0.62
Volatility % 19.97
14-Day RSI 41.98
14-Day ATR (€) 1.056997
20-Day SMA (€) 67.028
12-1 Month Momentum % 23.94
52-Week Range (€) 56 - 74.64
Shares Outstanding (Mil) 249.38

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Hologic Inc Filings

Document Form Filing Date
No Filing Data